In summary, our results demonstrated that baicalin protected EIC rats against cholestatic liver injury by restoring hepatic BA homeostasis and modulating the inflammatory response through activating the Sirt1/HNF-1α/FXR signaling pathway (Figure 8). The gene discussed is SIRT1; the disease is digestive system neoplasm.